Abstract This article reported the clinical characteristics and SRD5A2 gene mutation pattern of a child with steroid 5-α reductase type 2 deficiency. The 2-month-old boy showed hypospadias and short penis shortly after birth. DNA was extracted from the peripheral blood of the child and his parents. The endocrine disease-related genes were captured and sequenced by high-throughput sequencing technology, and the family DNA samples were verified by Sanger sequencing. The results showed that c.680G > A(p.R227Q) and c.608G > A(p.G203D) compound heterozygous mutations existed in the SRD5A2 gene of the child. The c.680G > A mutation inherited from his father, which was a known pathogenic mutation. The c.608G > A mutation originated from his mother, which was a novel mutation discovered in this study. These results provide molecular evidence for the etiological diagnosis of the child and genetic counseling for the family, as well as extend the mutation spectrum of SRD5A2 gene.
CHU Guo-Ming,LI Ping-Ping,CHANG Wen-Jing et al. Variant analysis on steroid 5-reductase type 2 deficiency caused by a novel SRD5A2 mutation[J]. CJCP, 2020, 22(7): 790-795.
CHU Guo-Ming,LI Ping-Ping,CHANG Wen-Jing et al. Variant analysis on steroid 5-reductase type 2 deficiency caused by a novel SRD5A2 mutation[J]. CJCP, 2020, 22(7): 790-795.
Wang T, Liu JH, Yang J, et al. 46,XX male sex reversal syndrome:a case report and review of the genetic basis[J]. Andrologia, 2009, 41(1):59-62.
[2]
Berglund A, Johannsen TH, Stochholm K, et al. Incidence, prevalence, diagnostic delay, and clinical presentation of female 46,XY disorders of sex development[J]. J Clin Endocrinol Metab, 2016, 101(12):4532-4540.
[3]
Tajima T, Fujieda K, Kouda N, et al. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency[J]. J Clin Endocrinol Metab, 2001, 86(8):3820-3825.
[4]
Miller WL. Mechanisms in endocrinology:rare defects in adrenal steroidogenesis[J]. Eur J Endocrinol, 2018, 179(3):R125-R141.
[5]
Ye L, Su ZJ, Ge RS. Inhibitors of testosterone biosynthetic and metabolic activation enzymes[J]. Molecules, 2011, 16(12):9983-10001.
[6]
Lund L, Engebjerg MC, Pedersen L, et al. Prevalence of hypospadias in Danish boys:a longitudinal study, 1977-2005[J]. Eur Urol, 2009, 55(5):1022-1026.
[7]
Thareja S. Steroidal 5α-reductase inhibitors:a comparative 3D-QSAR study review[J]. Chem Rev, 2015, 115(8):2883-2894.
[8]
Walsh PC, Madden JD, Harrod MJ, et al. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias[J]. N Engl J Med, 1974, 291(18):944-949.
[9]
Andersson S, Berman DM, Jenkins EP, et al. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism[J]. Nature, 1991, 354(6349):159-161.
[10]
Nagaraja MR, Gubbala SP, Delphine Silvia CRW, et al. Molecular diagnostics of disorders of sexual development:an Indian survey and systems biology perspective[J]. Syst Biol Reprod Med, 2019, 65(2):105-120.
[11]
Hiort O, Sinnecker GH, Willenbring H, et al. Nonisotopic single Strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency[J]. J Clin Endocrinol Metab, 1996, 81(9):3415-3418.
[12]
Gui B, Song Y, Su Z, et al. New insights into 5α-reductase type 2 deficiency based on a multi-centre study:regional distribution and genotype-phenotype profiling of SRD5A2 in 190 Chinese patients[J]. J Med Genet, 2019, 56(10):685-692.
[13]
Vilchis F, Ramos L, Méndez JP, et al. Molecular analysis of the SRD5A2 in 46,XY subjects with incomplete virilization:the P212R substitution of the steroid 5alpha-reductase 2 may constitute an ancestral founder mutation in Mexican patients[J]. J Androl, 2010, 31(4):358-364.
[14]
Avendaño A, Paradisi I, Cammarata-Scalisi F, et al. 5-α-Reductase type 2 deficiency:is there a genotype-phenotype correlation? A review[J]. Hormones (Athens), 2018, 17(2):197-204.
[15]
Cheng J, Lin R, Zhang W, et al. Phenotype and molecular characteristics in 45 Chinese children with 5α-reductase type 2 deficiency from South China[J]. Clin Endocrinol (Oxf), 2015, 83(4):518-526.
[16]
Mazen I, Gad YZ, Hafez M, et al. Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated Egyptian children with suspected 5alpha-reductase deficiency:prevalence of the G34R mutation[J]. Clin Endocrinol (Oxf), 2003, 58(5):627-631.
[17]
Leme de Calais FL, Soardi FC, Petroli RJ, et al. Molecular diagnosis of 5α-reductase type II deficiency in Brazilian siblings with 46,XY disorder of sex development[J]. Int J Mol Sci, 2011, 12(12):9471-9480.
[18]
Cai LQ, Zhu YS, Katz MD, et al. 5 alpha-reductase-2 gene mutations in the Dominican Republic[J]. J Clin Endocrinol Metab, 1996, 81(5):1730-1735.
[19]
Yang Y, Wang BA, Guo QH, et al. Clinical and genetic analysis of three Chinese patients with steroid 5α-reductase type 2 deficiency[J]. J Pediatr Endocrinol Metab, 2012, 25(11-12):1077-1082.
[20]
Kilcoyne KR, Mitchell RT. Effect of environmental and pharmaceutical exposures on fetal testis development and function:a systematic review of human experimental data[J]. Hum Reprod Update, 2019, 25(4):397-421.
